Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice

Background. Slow-acting symptomatic agents (chondroprotectors) in osteoarthritis (OA) combined therapy is a promising approach. Aim. To compare the real-world results of combined therapy with glycosaminoglycan-peptide complex (GPC) and diacerein with GPC monotherapy in treating knee OA. Materi...

Full description

Bibliographic Details
Published in:	Consilium Medicum
Main Authors:	Andrey E. Karateev, Elena Iu. Polishchuk, Alena S. Potapova, Elena V. Matyanova, Ekaterina S. Filatova, Svetlana I. Glukhova, Aleksander M. Lila
Format:	Article
Language:	Russian
Published:	ZAO "Consilium Medicum" 2023-05-01
Subjects:	osteoarthritis glycosaminoglycan-peptide complex diacerein combination efficacy safety
Online Access:	https://consilium.orscience.ru/2075-1753/article/viewFile/553441/132691

Similar Items

Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial
by: Andrei E. Karateev, et al.
Published: (2021-05-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

Diacerein for osteoarthritis: An open-label comparative trial
by: L. V. Luchikhina, et al.
Published: (2016-03-01)

Diacerein: A New Disease Modulating Agent in Osteoarthritis
by: Medhi B, et al.
Published: (2007-10-01)

Comparison Of Diacerein-Ginger With Diacerein Alone In Treating Knee Osteoarthritis
by: Mehtab Munir, et al.
Published: (2019-12-01)

Evaluation of the efficacy and safety of injectable glycosaminoglycan-peptide complex (GPC) in patients with osteoarthritis: a multicenter observational study GLADIOLUS (GPC in the treatment of osteoarthritis: a follow-up study of pain relief and local symptom reduction)
by: L. I. Alekseeva, et al.
Published: (2020-05-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Diacerein in the treatment of chronic musculoskeletal pain
by: E. Yu. Polishchuk, et al.
Published: (2022-06-01)

Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
by: I. B. Belyaeva, et al.
Published: (2022-08-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

Use of diacerein for the treatment of large joint osteoarthritis (A review of literature and the author’s own experience)
by: Rimma Mikhailovna Balabanova
Published: (2015-09-01)

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS
by: E. P. Sharapova, et al.
Published: (2017-12-01)

Pharmacological therapy in patients with osteoarthritis and metabolic disorders: focus on diacerein
by: O.V. Kuryata, et al.
Published: (2025-03-01)

Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis
by: Fan Zeng, et al.
Published: (2023-04-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

Diacerein-Loaded Hyaluosomes as a Dual-Function Platform for Osteoarthritis Management via Intra-Articular Injection: In Vitro Characterization and In Vivo Assessment in a Rat Model
by: Nouran O. Eladawy, et al.
Published: (2021-05-01)

Effect of diacerein on the clinical course of osteoarthritis and endothelial dysfunction in patients with arterial hypertension
by: Yu. P. Uspenskiy, et al.
Published: (2021-06-01)

Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes
by: Bibiane Steinecker-Frohnwieser, et al.
Published: (2017-09-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Efficacy and safety of the combined use of celecoxib, diacerein and a combination of glucosamine and chondroitin for the control of musculoskeletal pain associated with osteoarthritis and nonspecific back pain
by: A. E. Karateev, et al.
Published: (2023-10-01)

Glycosaminoglycan-peptide complex in the treatment of knee and hip osteoarthritis: from the past to the future
by: A. E. Karateev
Published: (2020-02-01)

NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME
by: L. I. Alexeeva, et al.
Published: (2018-02-01)

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study
by: L. I. Alekseeva, et al.
Published: (2021-02-01)

Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility–permeability relationship of counter ion and diacerein
by: Yan Liang, et al.
Published: (2022-12-01)

Glycosaminoglycans in osteoarthritis cartilage promote inflammation by preferential activation of the lipoxygenase rather than the cyclooxygenase pathway
by: Ana Carolina Matias Dinelly Pinto, et al.
Published: (2025-09-01)

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY
by: L. I. Alekseeva, et al.
Published: (2018-05-01)

EVALUATION OF THE EFFICACY AND SAFETY OF A GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX IN THE TREATMENT OF KNEE OSTEOARTHRITIS IN PATIENTS WITH PREVIOUS INEFFICIENCY OF SLOW-RELEASE ORAL ANTI-INFLAMMATORY DRUGS (THE MULTICENTER OPEN-LABEL STUDY PRIMULA: USE OF RUMALON® WITH INITIALLY SMALL SUCCESS IN THE TREATMENT OF OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2018-03-01)

Diacerein-loaded surface modified iron oxide microparticles (SMIOMPs): an emerging magnetic system for management of osteoarthritis via intra-articular injection
by: Nouran Abdelmageed Ali, et al.
Published: (2024-10-01)

Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
by: K. L. C. da Silva, et al.
Published: (2018-05-01)

Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1
by: Mohd Zahoor ul haq Shah, et al.
Published: (2024-07-01)

Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS)
by: Guoqi Cai, et al.
Published: (2022-09-01)

Renoprotective effect of diacerein in rats with partial unilateral ureteral obstruction model
by: Kölükçü Engin, et al.
Published: (2024-04-01)

Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data
by: Gary W. White
Published: (2025-09-01)

Development of composition and evaluation of equivalence of diacerein hard gelatin capsules
by: O. O. Saliy, et al.
Published: (2021-12-01)

Exploring the antibacterial and anti-biofilm properties of Diacerein against methicillin-resistant Staphylococcus aureus
by: Yingying Sun, et al.
Published: (2025-03-01)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
by: Chunyan Fu, et al.
Published: (2023-08-01)

An Injectable PEG/Diacerein‐Based Anti‐Inflammatory Hydrogel for Promoting Cartilage Regeneration: An In Vivo Study
by: Jing Mi, et al.
Published: (2025-05-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)